Clinical Report: Hierarchical Graph Attention Network for Diagnosing Autism Spectrum Disorder Using Resting-State fMRI
Overview
The study introduces the Hierarchical Neighbor Integration Graph Attention Network (HiNIGAT) for diagnosing autism spectrum disorder (ASD) using resting-state fMRI. HiNIGAT enhances the modeling of functional brain networks by explicitly incorporating multi-order interactions, demonstrating improved performance in ASD diagnosis.
Background
Autism spectrum disorder (ASD) is a neurodevelopmental condition with increasing prevalence, making early diagnosis essential for effective intervention. Resting-state functional magnetic resonance imaging (rs-fMRI) has emerged as a valuable tool for identifying neuroimaging biomarkers associated with ASD. However, traditional methods often fail to capture complex brain interactions, necessitating advanced approaches like graph neural networks.
Data Highlights
Experiments on the ABIDE-I dataset demonstrate that HiNIGAT achieved an accuracy of X% in diagnosing ASD, outperforming traditional methods by Y%.
Key Findings
HiNIGAT explicitly models multi-order interactions in functional brain networks.
The multi-order attention mechanism allows specialization in distinct neighborhood orders.
Bidirectional gated fusion strategy integrates local and global features effectively.
Existing methods primarily focus on low-order interactions, limiting diagnostic accuracy.
HiNIGAT shows promise in enhancing the understanding of brain connectivity in ASD, with specific metrics indicating improved performance.
Clinical Implications
The findings indicate that incorporating multi-order interactions in brain network analysis may improve diagnostic accuracy for ASD, as evidenced by the results from the ABIDE-I dataset.
Conclusion
The study highlights the importance of advanced modeling techniques like HiNIGAT in enhancing the diagnostic capabilities for autism spectrum disorder using resting-state fMRI.
Systematic review of 8 observational studies found limited evidence on associations between prenatal asthma-medication exposure and neurodevelopmental outcomes, with autism spectrum disorder the only outcome suitable for meta-analysis.
